The hematological cancer therapeutics market is expected to grow from USD 37.88 billion in 2020 to USD 82.40 billion by 2028, at a CAGR of 10.2% during the forecast period 2021-2028.
Hematological Cancer is a cancer that starts in blood-forming tissue like bone marrow or the cells of the immune system. Some of the known examples of hematological cancer include lymphoma, leukemia, and multiple myeloma. This type of cancer most often begins in the bone marrow, where the blood is produced. Further, the bone marrow's stem cells develop into red blood cells, white blood cells, or platelets.
The factors driving the market are increased funding for cancer research and development, increasing incidence of cancer, and technological advancements. The factors restraining the market growth are the high cost of the treatment, strict regulatory framework, and associated side effects of the hematological therapeutics.
This study delivers a comprehensive analysis of type, end-user, and region. The type segment is classified into anemia treatment, pharmacological therapies, steam cell transplantation, thrombosis treatment, surgery and radiation therapy, neutropenia treatment, and others. Pharmacological therapies segment held the largest market share of 23.76% in the year 2020, due to the rising prevalence of target diseases across the globe and increasing research and development in cancer therapeutics. Based on end-user, the market is segmented into clinical laboratories, hospitals, academic and research institutes, and others. Hospitals segment held the largest market share of 36.65% in the year 2020, owing to the increasing investments from both government and private bodies.
The market has been divided into North America, Europe, Asia-Pacific, Middle East & Africa, and South America. The Asia-Pacific region holds the largest market share, owing to the increasing investment in research and development in blood cancer therapeutics and increasing government hospital expenditure and infrastructure rate. In the region, China dominated the market due to a favorable regulatory scenario in China and a high prevalence of target diseases. North America is anticipated to witness significant growth due to the rising incidences of blood cancer and the strong presence of pharmaceutical companies.
Some of the notable players in the market are Johnson & Johnson, Roche, Mindray Medical, Karyopharm Therapeutics, AbbVie, Abbott Laboratories, Celgene, Novartis, Bio-Rad Laboratories, HemoCue AB, Sysmex, and Siemens AG.
Hematological Cancers Therapeutics Market Analysis and Forecast, Type
Hematological Cancers Therapeutics Market Analysis and Forecast, End-User
Hematological Cancers Therapeutics Market Analysis and Forecast, Region
Report Description:
The study also includes attractiveness analysis of all segments and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunist for understanding the future growth of the market.
1. Introduction
1.1. Objectives of the Study
1.2. Market Definition
1.3. Research Scope
1.4. Currency
1.5. Key Target Audience
2. Research Methodology and Assumptions
3. Executive Summary
4. Premium Insights
4.1. Porter’s Five Forces Analysis
4.2. Value Chain Analysis
4.3. Top Investment Pockets
4.3.1. Market Attractiveness Analysis By Type
4.3.2. Market Attractiveness Analysis By End-User
4.3.3. Market Attractiveness Analysis By Region
4.4. Industry Trends
5. Market Dynamics
5.1. Market Evaluation
5.2. Drivers
5.2.1. Increasing incidence of cancer
5.2.2. Technological advancements
5.3. Restraints
5.3.1. Side effects associated with haematological therapeutics
5.3.2. Strict regulatory framework
6. Global Hematological Cancer Therapeutics Market Analysis and Forecast, By Type
6.1. Segment Overview
6.2. Anemia Treatment
6.3. Pharmacological Therapies
6.4. Steam Cell Transplantation
6.5. Thrombosis Treatment
6.6. Surgery and Radiation Therapy
6.7. Neutropenia Treatment
6.8. Others
7. Global Hematological Cancer Therapeutics Market Analysis and Forecast, By End-User
7.1. Segment Overview
7.2. Clinical Laboratories
7.3. Hospitals
7.4. Academic and Research Institutes
7.5. Others
8. Global Hematological Cancer Therapeutics Market Analysis and Forecast, By Regional Analysis
8.1. Segment Overview
8.2. North America
8.2.1. U.S.
8.2.2. Canada
8.2.3. Mexico
8.3. Europe
8.3.1. Germany
8.3.2. France
8.3.3. U.K.
8.3.4. Italy
8.3.5. Spain
8.4. Asia-Pacific
8.4.1. Japan
8.4.2. China
8.4.3. India
8.5. South America
8.5.1. Brazil
8.6. Middle East and Africa
8.6.1. UAE
8.6.2. South Africa
9. Global Hematological Cancer Therapeutics Market-Competitive Landscape
9.1. Overview
9.2. Market Share of Key Players in Global Hematological Cancer Therapeutics Market
9.2.1. Global Company Market Share
9.2.2. North America Company Market Share
9.2.3. Europe Company Market Share
9.2.4. APAC Company Market Share
9.3. Competitive Situations and Trends
9.3.1. Material Launches and Developments
9.3.2. Partnerships, Collaborations, and Agreements
9.3.3. Mergers & Acquisitions
9.3.4. Expansions
10. Company Profiles
10.1. Johnson & Johnson
10.1.1. Business Overview
10.1.2. Company Snapshot
10.1.3. Company Market Share Analysis
10.1.4. Company Product Portfolio
10.1.5. Recent Developments
10.1.6. SWOT Analysis
10.2. Roche
10.2.1. Business Overview
10.2.2. Company Snapshot
10.2.3. Company Market Share Analysis
10.2.4. Company Product Portfolio
10.2.5. Recent Developments
10.2.6. SWOT Analysis
10.3. Mindray Medical
10.3.1. Business Overview
10.3.2. Company Snapshot
10.3.3. Company Market Share Analysis
10.3.4. Company Product Portfolio
10.3.5. Recent Developments
10.3.6. SWOT Analysis
10.4. Karyopharm Therapeutics
10.4.1. Business Overview
10.4.2. Company Snapshot
10.4.3. Company Market Share Analysis
10.4.4. Company Product Portfolio
10.4.5. Recent Developments
10.4.6. SWOT Analysis
10.5. AbbVie
10.5.1. Business Overview
10.5.2. Company Snapshot
10.5.3. Company Market Share Analysis
10.5.4. Company Product Portfolio
10.5.5. Recent Developments
10.5.6. SWOT Analysis
10.6. Abbott Laboratories
10.6.1. Business Overview
10.6.2. Company Snapshot
10.6.3. Company Market Share Analysis
10.6.4. Company Product Portfolio
10.6.5. Recent Developments
10.6.6. SWOT Analysis
10.7. Celgene
10.7.1. Business Overview
10.7.2. Company Snapshot
10.7.3. Company Market Share Analysis
10.7.4. Company Product Portfolio
10.7.5. Recent Developments
10.7.6. SWOT Analysis
10.8. Novartis
10.8.1. Business Overview
10.8.2. Company Snapshot
10.8.3. Company Market Share Analysis
10.8.4. Company Product Portfolio
10.8.5. Recent Developments
10.8.6. SWOT Analysis
10.9. Bio-Rad Laboratories
10.9.1. Business Overview
10.9.2. Company Snapshot
10.9.3. Company Market Share Analysis
10.9.4. Company Product Portfolio
10.9.5. Recent Developments
10.9.6. SWOT Analysis
10.10. HemoCue AB
10.10.1. Business Overview
10.10.2. Company Snapshot
10.10.3. Company Market Share Analysis
10.10.4. Company Product Portfolio
10.10.5. Recent Developments
10.10.6. SWOT Analysis
10.11. Sysmex
10.11.1. Business Overview
10.11.2. Company Snapshot
10.11.3. Company Market Share Analysis
10.11.4. Company Product Portfolio
10.11.5. Recent Developments
10.11.6. SWOT Analysis
10.12. Siemens AG
10.12.1. Business Overview
10.12.2. Company Snapshot
10.12.3. Company Market Share Analysis
10.12.4. Company Product Portfolio
10.12.5. Recent Developments
10.12.6. SWOT Analysis
List of Table
1. Global Hematological Cancer Therapeutics Market, By Type, 2020-2028 (USD Billion)
2. Global Anemia Treatment, Hematological Cancer Therapeutics Market, By Region, 2020-2028 (USD Billion)
3. Global Pharmacological Therapies, Hematological Cancer Therapeutics Market, By Region, 2020-2028 (USD Billion)
4. Global Stem Cell Transplantation, Hematological Cancer Therapeutics Market, By Region, 2020-2028 (USD Billion)
5. Global Thrombosis Treatment, Hematological Cancer Therapeutics Market, By Region, 2020-2028 (USD Billion)
6. Global Surgery and Radiation Therapy, Hematological Cancer Therapeutics Market, By Region, 2020-2028 (USD Billion)
7. Global Neutropenia Treatment, Hematological Cancer Therapeutics Market, By Region, 2020-2028 (USD Billion)
8. Global Others, Hematological Cancer Therapeutics Market, By Region, 2020-2028 (USD Billion)
9. Global Hematological Cancer Therapeutics Market, By End-User, 2020-2028 (USD Billion)
10. Global Clinical Laboratories, Hematological Cancer Therapeutics Market, By Region, 2020-2028 (USD Billion)
11. Global Hospitals, Hematological Cancer Therapeutics Market, By Region, 2020-2028 (USD Billion)
12. Global Academic and Research Institutes, Hematological Cancer Therapeutics Market, By Region, 2020-2028 (USD Billion)
13. Global Others, Hematological Cancer Therapeutics Market, By Region, 2020-2028 (USD Billion)
14. North America Hematological Cancer Therapeutics Market, By Type, 2020-2028 (USD Billion)
15. North America Hematological Cancer Therapeutics Market, By End-User, 2020-2028 (USD Billion)
16. U.S. Hematological Cancer Therapeutics Market, By Type, 2020-2028 (USD Billion)
17. U.S. Hematological Cancer Therapeutics Market, By End-User, 2020-2028 (USD Billion)
18. Canada Hematological Cancer Therapeutics Market, By Type, 2020-2028 (USD Billion)
19. Canada Hematological Cancer Therapeutics Market, By End-User, 2020-2028 (USD Billion)
20. Mexico Hematological Cancer Therapeutics Market, By Type, 2020-2028 (USD Billion)
21. Mexico Hematological Cancer Therapeutics Market, By End-User, 2020-2028 (USD Billion)
22. Europe Hematological Cancer Therapeutics Market, By Type, 2020-2028 (USD Billion)
23. Europe Hematological Cancer Therapeutics Market, By End-User, 2020-2028 (USD Billion)
24. Germany Hematological Cancer Therapeutics Market, By Type, 2020-2028 (USD Billion)
25. Germany Hematological Cancer Therapeutics Market, By End-User, 2020-2028 (USD Billion)
26. France Hematological Cancer Therapeutics Market, By Type, 2020-2028 (USD Billion)
27. France Hematological Cancer Therapeutics Market, By End-User, 2020-2028 (USD Billion)
28. U.K. Hematological Cancer Therapeutics Market, By Type, 2020-2028 (USD Billion)
29. U.K. Hematological Cancer Therapeutics Market, By End-User, 2020-2028 (USD Billion)
30. Italy Hematological Cancer Therapeutics Market, By Type, 2020-2028 (USD Billion)
31. Italy Hematological Cancer Therapeutics Market, By End-User, 2020-2028 (USD Billion)
32. Spain Hematological Cancer Therapeutics Market, By Type, 2020-2028 (USD Billion)
33. Spain Hematological Cancer Therapeutics Market, By End-User, 2020-2028 (USD Billion)
34. Asia Pacific Hematological Cancer Therapeutics Market, By Type, 2020-2028 (USD Billion)
35. Asia Pacific Hematological Cancer Therapeutics Market, By End-User, 2020-2028 (USD Billion)
36. Japan Hematological Cancer Therapeutics Market, By Type, 2020-2028 (USD Billion)
37. Japan Hematological Cancer Therapeutics Market, By End-User, 2020-2028 (USD Billion)
38. China Hematological Cancer Therapeutics Market, By Type, 2020-2028 (USD Billion)
39. China Hematological Cancer Therapeutics Market, By End-User, 2020-2028 (USD Billion)
40. India Hematological Cancer Therapeutics Market, By Type, 2020-2028 (USD Billion)
41. India Hematological Cancer Therapeutics Market, By End-User, 2020-2028 (USD Billion)
42. South America Hematological Cancer Therapeutics Market, By Type, 2020-2028 (USD Billion)
43. South America Hematological Cancer Therapeutics Market, By End-User, 2020-2028 (USD Billion)
44. Brazil Hematological Cancer Therapeutics Market, By Type, 2020-2028 (USD Billion)
45. Brazil Hematological Cancer Therapeutics Market, By End-User, 2020-2028 (USD Billion)
46. Middle East and Africa Hematological Cancer Therapeutics Market, By Type, 2020-2028 (USD Billion)
47. Middle East and Africa Hematological Cancer Therapeutics Market, By End-User, 2020-2028 (USD Billion)
48. UAE Hematological Cancer Therapeutics Market, By Type, 2020-2028 (USD Billion)
49. UAE Hematological Cancer Therapeutics Market, By End-User, 2020-2028 (USD Billion)
50. South Africa Hematological Cancer Therapeutics Market, By Type, 2020-2028 (USD Billion)
51. South Africa Hematological Cancer Therapeutics Market, By End-User, 2020-2028 (USD Billion)
List of Figures
1. Global Hematological Cancer Therapeutics Market Segmentation
2. Global Hematological Cancer Therapeutics Market: Research Methodology
3. Market Size Estimation Methodology: Bottom-Up Approach
4. Market Size Estimation Methodology: Top-Down Approach
5. Data Triangulation
6. Porter’s Five Forces Analysis
7. Value Chain Analysis
8. Global Hematological Cancer Therapeutics Market Attractiveness Analysis By Type
9. Global Hematological Cancer Therapeutics Market Attractiveness Analysis By End-User
10. Global Hematological Cancer Therapeutics Market Attractiveness Analysis By Region
11. Global Hematological Cancer Therapeutics Market: Dynamics
12. Global Hematological Cancer Therapeutics Market Share by Type (2021 & 2028)
13. Global Hematological Cancer Therapeutics Market Share by End-User (2021 & 2028)
14. Global Hematological Cancer Therapeutics Market Share by Regions (2021 & 2028)
15. Global Hematological Cancer Therapeutics Market Share by Company (2020)
Market research is a method of gathering, assessing and deducing data & information about a particular market. Market research is very crucial in these days. The techniques analyze about how a product/service can be offered to the market to its end-customers, observe the impact of that product/service based on the past customer experiences, and cater their needs and demands. Owing to the successful business ventures, accurate, relevant and thorough information is the base for all the organizations because market research report/study offers specific market related data & information about the industry growth prospects, perspective of the existing customers, and the overall market scenario prevailed in past, ongoing present and developing future. It allows the stakeholders and investors to determine the probability of a business before committing substantial resources to the venture. Market research helps in solving the marketing issues challenges that a business will most likely face.
Market research is valuable because of the following reasons:
Our research report features both the aspects; qualitative and quantitative. Qualitative part provides insights about the market driving forces, potential opportunities, customer’s demands and requirement which in turn help the companies to come up with new strategies in order to survive in the long run competition. The quantitative segment offers the most credible information related to the industry. Based on the data gathering, we use to derive the market size and estimate their future growth prospects on the basis of global, region and country.
Our market research process involves with the four specific stages.
Data Collection: This stage of the market research process involves with the gathering and collecting of the market/industry related data from the sources. There are basically two types of research methods:
Data Synthesis: This stage includes the evaluation and assessment of all the data acquired from the primary and secondary research. It likewise includes in evaluating the information for any disparity watched while information gathering identified with the market. The data & information is gathered with consideration to the heterogeneity of sources. Scientific and statistical methods are implemented for synthesizing dissimilar information sets and provide the relevant data which is fundamental for formulating strategies. Our organization has broad involvement with information amalgamation where the information goes through different stages:
Market Formulation & Deduction: The last stage includes assigning the data & information in a suitable way in order to derive market size. Analyst reviews and domain based opinions based on holistic approach of market estimation combined with industry investigation additionally features a crucial role in this stage.
This stage includes with the finalization of the market size and numbers that we have gathered from primary and secondary research. With the data & information addition, we ensure that there is no gap in the market information. Market trend analysis is finished by our analysts by utilizing data extrapolation procedures, which give the most ideal figures to the market.
Data Validation: Validation is the most crucial step in the process. Validation & re-validation through scientifically designed technique and process that helps us finalize data-points to be used for final calculations. This stage also involves with the data triangulation process. Data triangulation generally implicates the cross validation and matching the data which has been collected from primary and secondary research methods.
Free Customization
Countries can be added on demand
Free yearly update on purchase of Multi/Corporate User License
Companies served till date
We serve our customers 24x7 for 365 days through calls, emails and live chat options.
Huge database of exceptional market reports bringing market intelligence to your fingertips.
SSL enabled, we offer you various secured payment options for risk free purchase.